Drug · DIN 02528126
CAPECITABINE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 20, 2022.
- Drug Identification Number (DIN)
- 02528126
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Capecitabine L01BC06
- Class
- Human
- Record last updated
- June 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CAPECITABINE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 20, 2022: NOC 28434Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named CAPECITABINE
- DIN 02514982 · Marketed
- DIN 02514990 · Marketed
- DIN 02519879 · Marketed
- DIN 02519887 · Marketed
- DIN 02528150 · Approved